Department of Health
and Human Services (HHS)
and Human Services (HHS)
August 11, 2020
RFA-NS-21-001 - NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform applicants of a change to the late application policy for the September 28, 2020, Application Due Date for RFA-NS-21-001 "NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional)". The NINDS understands that the public health emergency related to the Coronavirus Disease (2019) will adversely affect applicants' ability to submit applications in a timely manner.
Late applications will be accepted through 5:00 PM local time October 13, 2020, for RFA-NS-21-001 "NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional)". No late applications submitted after October 13, 2020 will be considered.
A cover letter citing this Notice (NOT-NS-20-097) may be submitted, but it is not required.
For the September 28, 2021, and September 28, 2022, application due date(s), NIH Policy on Late Submission of Grant Applications NOT-OD-15-039 applies. This RFA is modified to no longer state, "No late applications will be accepted for this Funding Opportunity Announcement."
Application Due Date(s)
September 28, 2020, September 28, 2021, September 28, 2022
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Application Due Date(s)
September 28, 2020, September 28, 2021, September 28, 2022
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
All other aspects of this FOA remain unchanged.
Beth-Anne Sieber, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5680
Email: Beth-Anne.Sieber@nih.gov